The firm reported revenues of $15.53 billion and adjusted earnings per share of $2.22, surpassing consensus predictions of ...

Take Verve Therapeutics (NASDAQ: VERV), a small-cap, clinical-stage biotech. If Verve Therapeutics has any chance of soaring ...

The loans sat on banks’ books for two-and-a-half years until the election of Donald Trump rapidly changed the company’s ...

Heading into Meta's Q1 earnings, analysts are watching for key updates on AI initiatives, Instagram Reels, and growth in ad ...

Asian shares are mostly higher after U.S. stocks drifted to a mixed, quiet finish ahead of a busy week of corporate earnings ...

A group of banks including Morgan Stanley, Bank of America, Barclays and Mitsubishi UFJ sold the final piece of debt tied to ...

Alphabet, Apple, Nvidia and the rest of the so-called “Magnificent Seven”—have lost a quarter of their value. Investors have ...

General Motors is set to report its first-quarter earnings before the bell Tuesday. Wall Street analysts expect adjusted ...

A group of banks including Morgan Stanley, Bank of America, Barclays and Mitsubishi UFJ sold the final piece of debt tied to ...

U.S. stocks drifted to a mixed, quiet finish ahead of a week with several potential flashpoints that could bring more sharp ...

A new survey of consumers on Tuesday is expected to show attitudes worsened in April, casting further gloom over the economy ...

For the third quarter, Microsoft is expected to report earnings per share (EPS) of $3.21 on revenue of $68.4 billion, ...